Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC   MYLAN
EQUITY SHARE DATA
    FDC
Mar-23
MYLAN
Dec-18
FDC/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3183,967-   
Low Rs2292,184-   
Sales per share (Unadj.) Rs107.51,825.4-  
Earnings per share (Unadj.) Rs11.749.6-  
Cash flow per share (Unadj.) Rs14.0391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs119.51,974.7-  
Shares outstanding (eoy) m165.91514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.51.7 151.0%   
Avg P/E ratio x23.462.0 37.7%  
P/CF ratio (eoy) x19.57.9 248.0%  
Price / Book Value ratio x2.31.6 147.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m45,3681,582,214 2.9%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m3,9090-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m17,838939,158 1.9%  
Other income Rs m5120-   
Total revenues Rs m18,350939,158 2.0%   
Gross profit Rs m2,496243,019 1.0%  
Depreciation Rs m389175,847 0.2%   
Interest Rs m4145,170 0.1%   
Profit before tax Rs m2,57822,002 11.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m640-3,500 -18.3%   
Profit after tax Rs m1,93825,502 7.6%  
Gross profit margin %14.025.9 54.1%  
Effective tax rate %24.8-15.9 -156.0%   
Net profit margin %10.92.7 400.2%  
BALANCE SHEET DATA
Current assets Rs m14,431524,425 2.8%   
Current liabilities Rs m7,296382,364 1.9%   
Net working cap to sales %40.015.1 264.4%  
Current ratio x2.01.4 144.2%  
Inventory Days Days26584 317.0%  
Debtors Days Days25193 268.9%  
Net fixed assets Rs m17,347182,181 9.5%   
Share capital Rs m166500 33.2%   
"Free" reserves Rs m19,6550-   
Net worth Rs m19,8201,015,998 2.0%   
Long term debt Rs m61,096,588 0.0%   
Total assets Rs m31,7962,725,301 1.2%  
Interest coverage x64.11.5 4,309.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.60.3 162.8%   
Return on assets %6.22.6 240.0%  
Return on equity %9.82.5 389.6%  
Return on capital %13.23.2 415.4%  
Exports to sales %00-   
Imports to sales %8.50-   
Net fx Rs m1,7490-   
CASH FLOW
From Operations Rs m1,549195,157 0.8%  
From Investments Rs m111-100,875 -0.1%  
From Financial Activity Rs m-1,800-90,916 2.0%  
Net Cashflow Rs m-1381,617 -8.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare FDC With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare FDC With: BH.IMMUN&BIO  WALPAR NUTRITIONS LTD.  SAMRAT PHARMA  ALEMBIC  DISHMAN CARBOGEN AMCIS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.